Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.

Ziai W, Moullaali T, Nekoovaght-Tak S, Ullman N, Brooks JS, Morgan TC, Hanley DF.

Neurocrit Care. 2013 Jun;18(3):354-61. doi: 10.1007/s12028-013-9826-1.

PMID:
23463422
2.

Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.

Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, Narula R, Guo KH, Claassen J, Lee K, Badjatia N, Mayer SA, Connolly ES Jr.

Neurosurgery. 2010 Apr;66(4):648-55. doi: 10.1227/01.NEU.0000360374.59435.60.

PMID:
20305489
3.

Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage.

Volbers B, Wagner I, Willfarth W, Doerfler A, Schwab S, Staykov D.

Stroke. 2013 Feb;44(2):362-6. doi: 10.1161/STROKEAHA.112.673228. Epub 2013 Jan 10.

4.

Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.

Kramer AH, Jenne C, Holodinsky JK, Todd S, Roberts DJ, Kubes P, Zygun DA, Hill MD, Leger C, Wong JH.

Neurocrit Care. 2015 Dec;23(3):386-93. doi: 10.1007/s12028-015-0126-9.

PMID:
25739904
5.

Safety of intraventricular hemorrhage (IVH) thrombolysis based on CT localization of external ventricular drain (EVD) fenestrations and analysis of EVD tract hemorrhage.

Jackson DA, Patel AV, Darracott RM, Hanel RA, Freeman WD, Hanley DF.

Neurocrit Care. 2013 Aug;19(1):103-10. doi: 10.1007/s12028-012-9713-1.

6.

Minimally invasive evacuation of spontaneous intracerebral hemorrhage using sonothrombolysis.

Newell DW, Shah MM, Wilcox R, Hansmann DR, Melnychuk E, Muschelli J, Hanley DF.

J Neurosurg. 2011 Sep;115(3):592-601. doi: 10.3171/2011.5.JNS10505. Epub 2011 Jun 10.

7.
8.

Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator.

Mayfrank L, Kim Y, Kissler J, Delsing P, Gilsbach JM, Schröder JM, Weis J.

Acta Neuropathol. 2000 Nov;100(5):561-7.

PMID:
11045679
9.

Application of the Ommaya Reservoir in Managing Ventricular Hemorrhage.

Yang XT, Feng DF, Zhao L, Sun ZL, Zhao G.

World Neurosurg. 2016 May;89:93-100. doi: 10.1016/j.wneu.2015.12.040. Epub 2015 Dec 25.

PMID:
26724628
10.
11.

Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages.

Thiex R, Weis J, Krings T, Barreiro S, Yakisikli-Alemi F, Gilsbach JM, Rohde V.

J Neurosurg. 2007 Feb;106(2):314-20.

PMID:
17410717
12.

Intraclot recombinant tissue-type plasminogen activator reduces perihematomal edema and mortality in patients with spontaneous intracerebral hemorrhage.

Lian LF, Xu F, Tang ZP, Xue Z, Liang QM, Hu Q, Zhu WH, Kang HC, Liu XY, Wang FR, Zhu SQ.

J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):165-71. doi: 10.1007/s11596-014-1252-x. Epub 2014 Apr 8.

PMID:
24710926
13.

Factors affecting clot lysis rates in patients with spontaneous intraventricular hemorrhage.

Ziai WC, Muschelli J, Thompson CB, Keyl PM, Lane K, Shao S, Hanley DF.

Stroke. 2012 May;43(5):1234-9. doi: 10.1161/STROKEAHA.111.641050. Epub 2012 Mar 1.

14.

Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage.

Hinson HE, Melnychuk E, Muschelli J, Hanley DF, Awad IA, Ziai WC.

Neurocrit Care. 2012 Jun;16(3):399-405. doi: 10.1007/s12028-011-9569-9.

PMID:
21681594
15.

Early Quantification of Hematoma Hounsfield Units on Noncontrast CT in Acute Intraventricular Hemorrhage Predicts Ventricular Clearance after Intraventricular Thrombolysis.

Kornbluth J, Nekoovaght-Tak S, Ullman N, Carhuapoma JR, Hanley DF, Ziai W.

AJNR Am J Neuroradiol. 2015 Sep;36(9):1609-15. doi: 10.3174/ajnr.A4393. Epub 2015 Jul 30.

16.

A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III).

Ziai WC, Tuhrim S, Lane K, McBee N, Lees K, Dawson J, Butcher K, Vespa P, Wright DW, Keyl PM, Mendelow AD, Kase C, Wijman C, Lapointe M, John S, Thompson R, Thompson C, Mayo S, Reilly P, Janis S, Awad I, Hanley DF; CLEAR III Investigators.

Int J Stroke. 2014 Jun;9(4):536-42. doi: 10.1111/ijs.12097. Epub 2013 Aug 28.

PMID:
24033910
17.

Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.

Kramer AH, Roberts DJ, Holodinsky J, Todd S, Hill MD, Zygun DA, Faris P, Wong JH.

Neurocrit Care. 2014 Oct;21(2):275-84. doi: 10.1007/s12028-014-9965-z.

PMID:
24627207
18.

Evaluation of intraventricular hemorrhage assessment methods for predicting outcome following intracerebral hemorrhage.

Hwang BY, Bruce SS, Appelboom G, Piazza MA, Carpenter AM, Gigante PR, Kellner CP, Ducruet AF, Kellner MA, Deb-Sen R, Vaughan KA, Meyers PM, Connolly ES Jr.

J Neurosurg. 2012 Jan;116(1):185-92. doi: 10.3171/2011.9.JNS10850. Epub 2011 Oct 14.

PMID:
21999319
19.

No exacerbation of perihematomal edema with intraclot urokinase in patients with spontaneous intracerebral hemorrhage.

Lian L, Xu F, Hu Q, Liang Q, Zhu W, Kang H, Liu X, Tang Z, Zhu S.

Acta Neurochir (Wien). 2014 Sep;156(9):1735-44. doi: 10.1007/s00701-014-2130-9. Epub 2014 May 27.

PMID:
24861986
20.

Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis: Evaluating Accelerated Resolution of IVH (CLEAR IVH) program.

Webb AJ, Ullman NL, Mann S, Muschelli J, Awad IA, Hanley DF.

Stroke. 2012 Jun;43(6):1666-8. doi: 10.1161/STROKEAHA.112.650523. Epub 2012 Apr 3.

Supplemental Content

Support Center